ASX:PTX   PRESCIENT THERAPEUTICS LIMITED
So this is another clinical stager.... Coming along with PTX100 and PTX200 studied for breast cancer and incombination with citarabine for acute myeloid leukemia. Technically all levels above 0,13 are a buy!
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.